logo

Achieve Life Sciences Inc. (ACHV)



Trade ACHV now with
  Date
  Headline
9/18/2020 9:31:58 AM Achieve Life Sciences: RAUORA Trial Data Shows Significantly Fewer Side Effects With Higher Quit Rates For Cytisinicline
9/18/2020 7:09:44 AM Achieve Life Sciences Announces Results From Evaluation Of Cytisinicline Vs Chantix In 5-HT3 Receptor Study
8/4/2020 9:05:48 AM Achieve Life Sciences Prices Public Offering Of 476,187 Shares At $10.50/shr
8/4/2020 9:05:47 AM Achieve Life Sciences Prices Public Offering Of 476,187 Shares At $10.50 Per Share
6/29/2020 8:43:49 AM Achieve Life Sciences Says Cytisinicline Demonstrated Quit Rates At Least As Effective As Varenicline
6/29/2020 8:36:49 AM Achieve Life Sciences Prices $6 Mln Registered Direct Offering
5/14/2020 7:35:42 AM Achieve Life Sciences Q1 Net Loss Narrows To $3.32 Mln From $5.9 Mln Last Year
3/12/2020 5:31:28 AM Achieve Life Sciences To Present Additional Analyses From ORCA-1 Phase 2b Trial
2/6/2020 8:14:43 AM Achieve Life Sciences Retains FreeMind To Assist In Development Of Cytisinicline In Vaping And E-Cigarette Users